Philippe Auby

497 total citations
21 papers, 321 citations indexed

About

Philippe Auby is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Philippe Auby has authored 21 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Philippe Auby's work include Schizophrenia research and treatment (7 papers), Pharmaceutical studies and practices (5 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Philippe Auby is often cited by papers focused on Schizophrenia research and treatment (7 papers), Pharmaceutical studies and practices (5 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Philippe Auby collaborates with scholars based in France, United States and Denmark. Philippe Auby's co-authors include Robert D. McQuade, Ronald N. Marcus, Dan A. Oren, Tram Tran-Johnson, David A. Sack, Elyse Stock, Dan Zimbroff, George Manos, Florence Askénazy and Johannes Hamann and has published in prestigious journals such as PLoS ONE, Journal of the American Academy of Child & Adolescent Psychiatry and The Journal of Clinical Psychiatry.

In The Last Decade

Philippe Auby

20 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Auby France 10 240 133 70 37 31 21 321
Jamie Karagianis Canada 13 379 1.6× 128 1.0× 29 0.4× 51 1.4× 22 0.7× 26 508
Laura Jakimovich United States 7 412 1.7× 112 0.8× 87 1.2× 103 2.8× 30 1.0× 16 554
Margaret Harris United Kingdom 12 174 0.7× 105 0.8× 49 0.7× 35 0.9× 18 0.6× 19 381
Yanning Liu United States 5 358 1.5× 73 0.5× 73 1.0× 56 1.5× 41 1.3× 8 389
Mallik Greene United States 11 455 1.9× 92 0.7× 41 0.6× 70 1.9× 39 1.3× 49 563
Michael J. Reinstein United States 8 303 1.3× 187 1.4× 29 0.4× 48 1.3× 11 0.4× 13 386
Ralph Aquila United States 10 357 1.5× 111 0.8× 29 0.4× 77 2.1× 41 1.3× 15 446
Frank D. Gianfrancesco United States 13 524 2.2× 74 0.6× 35 0.5× 54 1.5× 64 2.1× 31 643
Baerbel Allingham United States 7 307 1.3× 55 0.4× 57 0.8× 27 0.7× 20 0.6× 10 365
Tram Tran-Johnson United States 8 237 1.0× 143 1.1× 42 0.6× 53 1.4× 5 0.2× 11 339

Countries citing papers authored by Philippe Auby

Since Specialization
Citations

This map shows the geographic impact of Philippe Auby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Auby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Auby more than expected).

Fields of papers citing papers by Philippe Auby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Auby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Auby. The network helps show where Philippe Auby may publish in the future.

Co-authorship network of co-authors of Philippe Auby

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Auby. A scholar is included among the top collaborators of Philippe Auby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Auby. Philippe Auby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandez, Arnaud, Florence Askénazy, Radia Zeghari, et al.. (2024). Somatic and Posttraumatic Stress Symptoms in Children and Adolescents in France. JAMA Network Open. 7(4). e247193–e247193. 4 indexed citations
2.
3.
Vandersteen, Clair, et al.. (2024). Impact of post-COVID-19 olfactory disorders on quality of life, hedonic experiences and psychiatric dimensions in general population. BMC Psychiatry. 24(1). 111–111. 4 indexed citations
4.
5.
Auby, Philippe, et al.. (2023). 5.70 Implementing Take-Pause, a Mindful Breathing System in Virtual Reality, as a Stress Reduction Tool in a Pediatric Urgent Care in Northern California: Interim Results. Journal of the American Academy of Child & Adolescent Psychiatry. 62(10). S281–S282. 1 indexed citations
6.
7.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders. Journal of Child and Adolescent Psychopharmacology. 28(1). 47–54. 15 indexed citations
8.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2017). Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients. Journal of Child and Adolescent Psychopharmacology. 27(6). 526–534. 15 indexed citations
9.
Findling, Robert L., Adelaide S. Robb, Melissa P. DelBello, et al.. (2016). 4.62 A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS. Journal of the American Academy of Child & Adolescent Psychiatry. 55(10). S183–S183. 1 indexed citations
10.
Thümmler, Susanne, et al.. (2014). Preliminary and ongoing French multicenter prospective naturalistic study of adverse events of antipsychotic treatment in naive children and adolescents. Child and Adolescent Psychiatry and Mental Health. 8(1). 18–18. 14 indexed citations
11.
Auby, Philippe. (2014). The European Union Pediatric legislation: impact on pharmaceutical research in pediatric populations. Clinical Investigation. 4(11). 1013–1019. 1 indexed citations
12.
Askénazy, Florence, et al.. (2014). Améliorer la surveillance de la tolérance pédiatrique des antipsychotiques en France. Archives de Pédiatrie. 22(1). 92–97. 4 indexed citations
13.
Auby, Philippe. (2008). Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective. Child and Adolescent Psychiatry and Mental Health. 2(1). 38–38. 14 indexed citations
14.
Zimbroff, Dan, Ronald N. Marcus, George Manos, et al.. (2007). Management of Acute Agitation in Patients With Bipolar Disorder. Journal of Clinical Psychopharmacology. 27(2). 171–176. 70 indexed citations
15.
Tran-Johnson, Tram, David A. Sack, Ronald N. Marcus, et al.. (2007). Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation. The Journal of Clinical Psychiatry. 68(1). 111–119. 93 indexed citations
16.
Abe, Kiyoshi, et al.. (2007). Actualité des données sur les modalités évolutives de la schizophrénie. Encyclopédie médico-chirurgicale. Psychiatrie. 23(1). 1–9. 1 indexed citations
17.
Hamann, Johannes, et al.. (2003). Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database. International Clinical Psychopharmacology. 18(4). 237–242. 26 indexed citations
18.
Hamann, Johannes, et al.. (2003). Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database. International Clinical Psychopharmacology. 18(4). 237–242. 5 indexed citations
19.
Bourin, Michel, et al.. (2003). P.2.121 Aripiprazole vs. haloperidol for maintained treatment effect in acute mania. European Neuropsychopharmacology. 13. S333–S333. 15 indexed citations
20.
Auby, Philippe, et al.. (2002). Safety and tolerability of aripiprazole at doses higher than 30 mg. European Neuropsychopharmacology. 12. 288–288. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie Karagianis Breakdown of academic impact, for papers by Laura Jakimovich Breakdown of academic impact, for papers by Margaret Harris Breakdown of academic impact, for papers by Yanning Liu Breakdown of academic impact, for papers by Mallik Greene Breakdown of academic impact, for papers by Michael J. Reinstein Breakdown of academic impact, for papers by Ralph Aquila Breakdown of academic impact, for papers by Frank D. Gianfrancesco Breakdown of academic impact, for papers by Baerbel Allingham Breakdown of academic impact, for papers by Tram Tran-Johnson
Rankless by CCL
2026